Background: Valemetostat tosylate (DS-3201b; valemetostat) is a first-in-class dual inhibitor targeting the epigenetic regulators EZH1 and EZH2. In Japan, valemetostat has been approved for the ...

Dactolisib tosylate + everolimus overview. Dactolisib tosylate in combination with everolimus is under development for the treatment of aging-related immunosenescence, respiratory tract infection, ...

Dactolisib tosylate is under clinical development by Adicet Bio and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to GlobalData, Phase II drugs for Coronavirus Disease 2019 ...

Bloomingdale, IL—NOW has shared the latest results of its industry self-policing program of testing unfamiliar brands sold on online in an effort to expose and address low-quality products in the ...

Review the side-effects of Bretylium Tosylate Injection as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

INTRODUCTION. Tosufloxacin tosylate (TFLX) is a third-generation quinolone antibacterial drug. It was originally developed by Toyama Chemical Co., Ltd. in 1986, followed by double-blind, comparative ...

Valemetostat tosylate (DS-3201b; valemetostat) is a potential first-in-class dual inhibitor of EZH1 and EZH2 that targets epigenetic regulations by inhibiting both EZH1 and EZH2 enzymes. A phase 2 ...

Suzhou Zelgen Biopharmaceuticals Co. Ltd. won approval from China’s NMPA for Zepsun (donafenib tosylate) to treat patients with unresectable hepatocellular carcinoma (HCC) who have not received ...